Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Hedge Funds-News

13G Filing: Knoll Capital Management Files on Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Published on March 1, 2016 at 3:07 pm by Meena Krishnamsetty in Hedge Funds, News
Page 1 of 7
Next >>

We are seeing a lot of 13G filing activity at the moment, with Fred Knoll‘s Knoll Capital Management having issued three of them, all on some of the fund’s top stock picks at the end of 2015. This filing details the investor’s latest position in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), which amounts to 2.56 million shares, giving it a 5.96% ownership stake in the company. Given the investor’s prominent position in the stock, we recommend paying close attention to the details in the following filing if you’re considering how to trade the company’s stock right now.

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Knoll Capital Management 0 2,563,925 0 2,563,925 2,563,925 5.96%
Fred Knoll 0 2,563,925 0 2,563,925 2,563,925 5.96%
Gakasa Holdings 0 2,563,925 0 2,563,925 2,563,925 5.96%

Follow Fred Knoll's Knoll Capital Management

Page 1 of 7 SEC Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
SCHEDULE 13G*
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2
(Amendment No. ___)*
Corbus Pharmaceuticals Holdings, Inc.
(Name of Issuer)
Common Stock, $0.0001 par value per share
(Title of Class of Securities)

21833P103
(CUSIP Number)

February
16, 2016
(Date of Event Which Requires Filing of the Statement)

Check the appropriate box to designate
the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)
x Rule 13d-1(c)
¨ Rule 13d-1(d)

*The remainder of this
cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover
page.

The information required
on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities
Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject
to all other provisions of the Act (however, see the Notes)

Page 1 of 7

Follow Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)








Page 1 of 7
Next >>

Show more...Show less

Related Insider Monkey Articles
Insider And Smart Money Move Into Corbus Pharmaceuticals As Pipeline Progresses...Do Hedge Funds Love Corbus Pharmaceuticals Holdings Inc (CRBP)?
Why Are These Stocks Shining Bright Today?